According to a new report published by Allied Market Research, titled, “Transcatheter Aortic valve Implantation (TAVI) Market by Procedure Type: Global Opportunity Analysis and Industry Forecast, 2021–2030,” the global TAVI market was valued at $4.56 billion in 2020, and is estimated to reach $16.94 billion by 2030, growing at a CAGR of 14.0% from 2021 to 2030.
♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞:
https://www.alliedmarketresearch.com/request-sample/1675
Key Findings of the Study –
- By procedure, the transfemoral and subclavian segment was the highest contributor to the TAVI market in 2020.
- Region wise, Europe garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
The report segments the TAVI market based on the method or technique used for implantation. A variety of approaches are used to insert a transcatheter aortic valve in patients including the transfemoral approach, the subclavian approach and others. Femoral implantation is described as a standardized TAVI procedure, in which an artificial valve is inserted through the femoral artery with minimal trauma. The wire is placed retrograde through the aortic arch. Many doctors have accepted the procedure because of the positive results.
Europe accounted for the largest share of the global Transcatheter Aortic Valve Implantation (TAVI) market in 2020 and is expected to remain dominant during the forecast period. This is due to the increasing prevalence of aortic stenosis and the high rate of adoption of transcatheter aortic valves in this area. In addition, favorable reimbursement policies in some European countries are the main factors increasing the acceptance of the TAVI procedure in this region.
♦ 𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/purchase-enquiry/1675
Severe respiratory disease corona virus-2 (SARS-CoV-2) is an infectious disease caused by the novel coronavirus (COVID-19), which originated in the Wuhan district of China in late 2019. The virus was previously called “2019 novel coronavirus” (2019-nCoV) of the WHO, however, on February 11, 2020, the International Committee on Taxonomy of Viruses gave it the official name SARS-CoV-2. WHO declared COVID-19 as a pandemic on March 11, 2020. The COVID-19 pandemic has led to some changes in the management of TAVI, as a large number of hospitals around the world have been reorganized to increase hospital capacity for diagnosed patients. and COVID -19.
Key Market Players –
Major key players that operate in the industry are Abbott Laboratories, Blue Sail Medical, Boston Scientific Corporation, Bracco, Edward Life Sciences, JC Medical, JenaValve, Medtronic Plc., Meril Life Sciences, and Venus Medtech.
By Region –
North America (U.S., Canada, Mexico)
Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
♦ 𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐡𝐢𝐬 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/checkout-final/39ad31fcac2c1972a2feb96cebed8ffd
Frequently Asked Questions?
Q1. What is the total market value of global TAVI market?
Q2. Which market holds the maximum market share of the global TAVI market?
Q3. What will be global TAVI market growth in 2030?
Q4. What are the key trends in the global TAVI market?
Q5. What are the key growth strategies of global TAVI market players? Q6. How the company profile has been selected?
About Us –
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com